159 research outputs found
Comunicación entre el personal sanitario y el paciente afásico
Comunicación oral presentada en la Segunda Conferencia Internacional de Comunicación en Salud, celebrada el 23 de octubre de 2015 en la Universidad Carlos III de MadridIntroducción: la afasia es la pérdida de capacidad de expresión debida a una lesión temporal o crónica de los centros temporales. Se calcula que en España hay unos 300.000 casos. Las limitaciones varían dependiendo del área dañada, viéndose afectada su capacidad para hablar, leer, escribir o comprender. Objetivos: Conocer los principales errores
que comete el personal sanitario al comunicarse con el paciente afásico. Mostrar alternativas de comunicación entre paciente y personal sanitario. Fomentar la comunicación interprofesional. Metodología: se realiza una búsqueda bibliográfica en las bases de datos Dialnet, Lilacs, Medline y Cuiden Plus con las palabras “comunicación” “paciente” “afasia” para artículos a texto completo publicados en los últimos diez años. Resultados: la búsqueda ofreció resultados,
que después proceso de selección se redujeron a cuatro artículos. Resultados: la bibliografía sobre la temática
del estudio es escasa, la mayoría de los estudios se centran en el ámbito logopédico. Los profesionales que a diario se relacionan conel paciente afásico, carecen de formación en habilidades comunicativas, consecuencia de esro es que nos enfrentamos a una comunicación personal-paciente ineficaz reflejada en frustración en ambos. Se evidencia la necesidad de futuras líneas de investigación sobre este tema, con el fin, de mejorar la calidad de vida del enfermo afásico; así como
fomentar el dialogo entre logopedas y el resto de profesionales sanitarios
Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation
Several psychiatric, neurologic and neurodegenerative disorders present increased brain ventricles volume, being hydrocephalus the disease with the major manifestation of ventriculomegaly caused by the accumulation of high amounts of cerebrospinal fluid (CSF). The molecules and pathomechanisms underlying cerebral ventricular enlargement are widely unknown. Kinase D interacting substrate of 220 kDa (KIDINS220) gene has been recently associated with schizophrenia and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity (SINO syndrome), diseases frequently occurring with ventriculomegaly. Here we show that Kidins220, a transmembrane protein effector of various key neuronal signalling pathways, is a critical regulator of CSF homeostasis. We observe that both KIDINS220 and the water channel aquaporin-4 (AQP4) are markedly downregulated at the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. We also find that Kidins220 deficient mice develop ventriculomegaly accompanied by water dyshomeostasis and loss of AQP4 in the brain ventricular ependymal layer and astrocytes. Kidins220 is a known cargo of the SNX27-retromer, a complex that redirects endocytosed plasma membrane proteins (cargos) back to the cell surface, thus avoiding their targeting to lysosomes for degradation. Mechanistically, we show that AQP4 is a novel cargo of the SNX27-retromer and that Kidins220 deficiency promotes a striking and unexpected downregulation of the SNX27-retromer that results in AQP4 lysosomal degradation. Accordingly, SNX27 silencing decreases AQP4 levels in wild-type astrocytes whereas SNX27 overexpression restores AQP4 content in Kidins220 deficient astrocytes. Together our data suggest that the KIDINS220-SNX27-retromer-AQP4 pathway is involved in human ventriculomegaly and open novel therapeutic perspectives
First Glimpse of the N= 82 Shell Closure below Z= 50 from Masses of Neutron-Rich Cadmium Isotopes and Isomers
We probe the N = 82 nuclear shell closure by mass measurements of neutron-rich cadmium isotopes with the ISOLTRAP spectrometer at ISOLDE-CERN. The new mass of 132 Cd offers the first value of the N = 82 , two-neutron shell gap below Z = 50 and confirms the phenomenon of mutually enhanced magicity at 132 Sn . Using the recently implemented phase-imaging ion-cyclotron-resonance method, the ordering of the low-lying isomers in 129 Cd and their energies are determined. The new experimental findings are used to test large-scale shell-model, mean-field, and beyond-mean-field calculations, as well as the ab initio valence-space in-medium similarity renormalization group
The Imaging Magnetograph eXperiment (IMaX) for the Sunrise balloon-borne solar observatory
The Imaging Magnetograph eXperiment (IMaX) is a spectropolarimeter built by
four institutions in Spain that flew on board the Sunrise balloon-borne
telesocope in June 2009 for almost six days over the Arctic Circle. As a
polarimeter IMaX uses fast polarization modulation (based on the use of two
liquid crystal retarders), real-time image accumulation, and dual beam
polarimetry to reach polarization sensitivities of 0.1%. As a spectrograph, the
instrument uses a LiNbO3 etalon in double pass and a narrow band pre-filter to
achieve a spectral resolution of 85 mAA. IMaX uses the high Zeeman sensitive
line of Fe I at 5250.2 AA and observes all four Stokes parameters at various
points inside the spectral line. This allows vector magnetograms, Dopplergrams,
and intensity frames to be produced that, after reconstruction, reach spatial
resolutions in the 0.15-0.18 arcsec range over a 50x50 arcsec FOV. Time
cadences vary between ten and 33 seconds, although the shortest one only
includes longitudinal polarimetry. The spectral line is sampled in various ways
depending on the applied observing mode, from just two points inside the line
to 11 of them. All observing modes include one extra wavelength point in the
nearby continuum. Gauss equivalent sensitivities are four Gauss for
longitudinal fields and 80 Gauss for transverse fields per wavelength sample.
The LOS velocities are estimated with statistical errors of the order of 5-40
m/s. The design, calibration and integration phases of the instrument, together
with the implemented data reduction scheme are described in some detail.Comment: 17 figure
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
Sarcomas are mesenchymal cancers with poor prognosis, representing about 20% of all solid malignancies in children,
adolescents, and young adults. Radio- and chemoresistance are common features of sarcomas warranting the search
for novel prognostic and predictive markers. GARP/LRRC32 is a TGF-β-activating protein that promotes immune
escape and dissemination in various cancers. However, if GARP affects the tumorigenicity and treatment resistance of
sarcomas is not known. We show that GARP is expressed by human osteo-, chondro-, and undifferentiated
pleomorphic sarcomas and is associated with a significantly worse clinical prognosis. Silencing of GARP in bone
sarcoma cell lines blocked their proliferation and induced apoptosis. In contrast, overexpression of GARP promoted
their growth in vitro and in vivo and increased their resistance to DNA damage and cell death induced by etoposide,
doxorubicin, and irradiation. Our data suggest that GARP could serve as a marker with therapeutic, prognostic, and
predictive value in sarcoma. We propose that targeting GARP in bone sarcomas could reduce tumour burden while
simultaneously improving the efficacy of chemo- and radiotherapy.Instituto de Salud Carlos IIIEuropean Union (EU)
PI15/00794
PI18/00826
CPII15/00032
PI15/02015Junta de Andalucía
C-0013-2018Spanish Government
PEJ-2014-A-46314Agencia Estatal de Investigación (AEI) [MICINN/Fondo Europeo de Desarrollo Regional (FEDER)]
SAF-2016-75286-RISCIII/FEDER [Miguel Servet Program]
CPII16/00049ISCIII/FEDER [Sara Borrell Program]
CD16/00103Servicio de Salud del Principado de Asturias, Instituto de Salud Carlos III
PT17/0015/0023Fundación Bancaria Cajastur
PT17/0015/0023ISCIII/FEDER [Consorcio CIBERONC]
CB16/12/0039
NGC6240: Merger-Induced Star Formation & Gas Dynamics
We present spatially resolved integral field spectroscopic K-band data at a
resolution of 0.13" (60pc) and interferometric CO(2-1) line observations of the
prototypical merging system NGC6240. Despite the clear rotational signature,
the stellar kinematics in the two nuclei are dominated by dispersion. We use
Jeans modelling to derive the masses and the mass-to-light ratios of the
nuclei. Combining the luminosities with the spatially resolved Br-gamma
equivalent width shows that only 1/3 of the K-band continuum from the nuclei is
associated with the most recent star forming episode; and that less than 30% of
the system's bolometric luminosity and only 9% of its stellar mass is due to
this starburst. The star formation properties, calculated from typical merger
star formation histories, demonstrate the impact of different assumptions about
the star formation history. The properties of the nuclei, and the existence of
a prominent old stellar population, indicate that the nuclei are remnants of
the progenitor galaxies' bulges.Comment: 18 pages, 14 figures. Accepted for publication in A&
A First Search for coincident Gravitational Waves and High Energy Neutrinos using LIGO, Virgo and ANTARES data from 2007
We present the results of the first search for gravitational wave bursts
associated with high energy neutrinos. Together, these messengers could reveal
new, hidden sources that are not observed by conventional photon astronomy,
particularly at high energy. Our search uses neutrinos detected by the
underwater neutrino telescope ANTARES in its 5 line configuration during the
period January - September 2007, which coincided with the fifth and first
science runs of LIGO and Virgo, respectively. The LIGO-Virgo data were analysed
for candidate gravitational-wave signals coincident in time and direction with
the neutrino events. No significant coincident events were observed. We place
limits on the density of joint high energy neutrino - gravitational wave
emission events in the local universe, and compare them with densities of
merger and core-collapse events.Comment: 19 pages, 8 figures, science summary page at
http://www.ligo.org/science/Publication-S5LV_ANTARES/index.php. Public access
area to figures, tables at
https://dcc.ligo.org/cgi-bin/DocDB/ShowDocument?docid=p120000
Dietary Protein Intake and Incidence of Type 2 Diabetes in Europe: The EPIC-INTERACT Case-Cohort Study
OBJECTIVEThe long-term association between dietary protein and type 2 diabetes incidence is uncertain. We aimed to investigate the association between total, animal, and plant protein intake and the incidence of type 2 diabetes.RESEARCH DESIGN AND METHODSThe prospective European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study consists of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 individuals from eight European countries, with an average follow-up time of 12.0 years. Pooled country-specific hazard ratios (HRs) and 95% CI of prentice-weighted Cox regression analyses were used to estimate type 2 diabetes incidence according to protein intake.RESULTSAfter adjustment for important diabetes risk factors and dietary factors, the incidence of type 2 diabetes was higher in those with high intake of total protein (per 10 g: HR 1.06 [95% CI 1.02-1.09], Ptrend 30 kg/m(2) (per 10 g animal protein: 1.19 [1.09-1.32]), and nonsignificant in men. Plant protein intake was not associated with type 2 diabetes (per 10 g: 1.04 [0.93-1.16], Ptrend = 0.098).CONCLUSIONSHigh total and animal protein intake was associated with a modest elevated risk of type 2 diabetes in a large cohort of European adults. In view of the rapidly increasing prevalence of type 2 diabetes, limiting iso-energetic diets high in dietary proteins, particularly from animal sources, should be considered
Testing ab initio nuclear structure in neutron-rich nuclei: Lifetime measurements of second 2+ state in 16C and 20O
To test the predictive power of ab initio nuclear structure theory, the lifetime of the second 2+ state in neutron-rich 20O,τ(2+2)=150+80−30fs, and an estimate for the lifetime of the second 2+ state in 16C have been obtained for the first time. The results were achieved via a novel Monte Carlo technique that allowed us to measure nuclear state lifetimes in the tens-to-hundreds of femtoseconds range by analyzing the Doppler-shifted γ-transition line shapes of products of low-energy transfer and deep-inelastic processes in the reaction 18O(7.0MeV/u)+181Ta. The requested sensitivity could only be reached owing to the excellent performances of the Advanced γ-Tracking Array AGATA, coupled to the PARIS scintillator array and to the VAMOS++ magnetic spectrometer. The experimental lifetimes agree with predictions of ab initio calculations using two- and three-nucleon interactions, obtained with the valence-space in-medium similarity renormalization group for 20O and with the no-core shell model for 16C. The present measurement shows the power of electromagnetic observables, determined with high-precision γ spectroscopy, to assess the quality of first-principles nuclear structure calculations, complementing common benchmarks based on nuclear energies. The proposed experimental approach will be essential for short lifetime measurements in unexplored regions of the nuclear chart, including r-process nuclei, when intense beams, produced by Isotope Separation On-Line (ISOL) techniques, become available
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study
Introduction: The relationship between circulating prolactin and invasive breast cancer has been investigated previously, but the association between prolactin levels and in situ breast cancer risk has received less attention. Methods: We analysed the relationship between pre-diagnostic prolactin levels and the risk of in situ breast cancer overall, and by menopausal status and use of postmenopausal hormone therapy (HT) at blood donation. Conditional logistic regression was used to assess this association in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, including 307 in situ breast cancer cases and their matched control subjects. Results: We found a significant positive association between higher circulating prolactin levels and risk of in situ breast cancer among all women [pre-and postmenopausal combined, ORlog2 = 1.35 (95% CI 1.04-1.76), P-trend = 0.03]. No statistically significant heterogeneity was found between prolactin levels and in situ cancer risk by menopausal status (P-het = 0.98) or baseline HT use (P-het = 0.20), although the observed association was more pronounced among postmenopausal women using HT compared to non-users (P-trend = 0.06 vs P-trend = 0.35). In subgroup analyses, the observed positive association was strongest in women diagnosed with in situ breast tumors = 4 years after blood donation (P-trend = 0.01 vs P-trend = 0.63; P-het = 0.04) and among nulliparous women compared to parous women (P-trend = 0.03 vs P-trend = 0.15; P-het = 0.07). Conclusions: Our data extends prior research linking prolactin and invasive breast cancer to the outcome of in situ breast tumours and shows that higher circulating prolactin is associated with increased risk of in situ breast cancer. The relationship between circulating prolactin and invasive breast cancer has been investigated previously, but the association between prolactin levels and in situ breast cancer risk has received less attention
- …